Multidisciplinary therapy for gastric cancer with liver metastasis.
- Author:
Lin CHEN
1
;
Hongqing XI
;
Weisong SHEN
Author Information
1. Department of General Surgery, Chinese PLA General Hospital, Beijing 100853, China. chenlinbj@vip.sina.com.
- Publication Type:Editorial
- MeSH:
Humans;
Liver Neoplasms;
secondary;
therapy;
Stomach Neoplasms;
pathology;
therapy
- From:
Chinese Journal of Gastrointestinal Surgery
2014;17(2):101-104
- CountryChina
- Language:Chinese
-
Abstract:
Gastric cancer with liver metastasis (GCLM) is the leading cause of death in patients with advanced gastric cancer. Multiple metastasis was common in GCLM and usually complicated with lesions outside the liver, especially peritoneal metastasis. Most of liver metastasis lesions could not be resected radically. Currently, main treatments for GCLM included radical operation, palliative resection of gastric cancer, ablation of metastatic lesions, intervention and systemic chemotherapy. Based on the current progress in the treatment for GCLM and our clinical experience, the general status of patients, the type of gastric cancer and the degree of liver metastasis should be analyzed, and a cooperative multidisciplinary team (MDT) should be applied to conduct and to choose active and suitable comprehensive treatment for GCLM patients based on individualized therapy principle.
